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Results
Baseline Characteristics (n = 46)
Background
Falls are a major threat for older adults as they can lead 
to increased risk of further injury, loss of independence, 
decreased mobility, and premature death.1,2 Even a 
single fall puts an older adult at higher risk for future 
falls. Despite numerous studies showing evidence that 
multifactorial fall risk interventions are effective in 
decreasing fall risk, even older adults who have an 
injurious fall often do not receive meaningful 
interventions to mitigate their fall risk. 3,4,5 Modifiable 
and non-modifiable risk factors may predispose older 
adults to falling. High-risk medication (HRM) use is one 
such modifiable fall risk factor. PCPs often express a lack 
of time and limited knowledge regarding the risks of 
HRMs as barriers to deprescribing.6 Studies have 
demonstrated that primary care pharmacists can help 
bridge that gap and play an important role in the 
interdisciplinary healthcare team, by identifying and 
intervening to reduce HRMs use in older adults.7
Purpose
The objective of this study is to evaluate the impact of 
medication-related interventions for older adults who 
had a fall-related ED visit, as part of a larger study of 
multifactorial fall-risk interventions in the primary care 
setting. This study will also evaluate to what degree 
medication-related recommendations were adopted by 
the primary care provider (PCP) over a minimum period 
of 7 months of follow-up.
Outcomes
• Number of HRM discontinued or tapered
• Overall reduction in number of medications
• Initiation of osteoporosis prevention or treatment
• Change in blood pressure (BP) or A1c goals
• Number of fall-related ED visits
Methods
Study Design:
• Four clinical pathways were assigned based on 
patient’s fall risk score, presence of cognitive 
impairment, and frailty status.
• Retrospective chart review of Pathways 1 - 4 from 
the SAFER pilot at four primary care clinics. 
Timeline: 
• December 2018 to June 2019
Inclusion criteria: 
• Enrolled in the SAFER pilot project
• Adults ≥75 years
• Presented to an ED for a fall
• Taking ≥1 HRM that is associated with increased 
falls
Exclusion criteria: 
• Not been seen in clinic in the last two years
• Enrolled in hospice or currently hospitalized 
• Discharged to a skilled nursing facility (SNF) 
• Died within two weeks of ED visit
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Preliminary Conclusions
• Results reflect a select case review in preparation for 
more comprehensive data review and analysis.
• Of sample, 117 medication-related recommendations 
were made by the Geriatric and PharmD teams (avg of 
4.7 per patient). Of those, a total of 52 changes (44%) 
were implemented by the PCP.
• The most accepted recommendations included ordering 
DEXA, orthostatic testing, adding Vitamin D, and 
discontinuing opioids.
• Not all medication changes reflected exact 
recommendations made by the Geriatric and PharmD 
teams.  Recommendations were generally aligned with 
overall goals suggested for patient.
• In patients on blood pressure medications, 69% did not 
have BP goals clearly defined by the PCP on their 
problem list. Of those, almost 59% had at least one 
systolic BP reading <110mmHg prior to SAFER 
enrollment. Given these patients are at high risk to fall, 
more lenient BP goals may be indicated.   
• Only 35% of the 46 patients have received an 
orthostatic test in the last 12 months prior to 
enrollment. 35% received testing post enrollment. Of 
those patients who received orthostatic testing 
following recommendation, 50% had adjustments made 
to their BP regimen.
• In those patients with diabetes, 50% did not have A1c 
goals cleared defined by their PCP on the problem list. 
• Only 25 patients (54%) received either Geriatric E-
consults or PharmD consults despite every patient being 
on at least 1 HRM. This suggests that potentially more 
changes could have been implemented if a consult was 
conducted. The process of referring to a PharmD for a 
consult will need to be reviewed.
Limitations:
• Study is a retrospective chart review. 
• Control group with which to compare data is not yet 
available.
• Follow-up timeframe of seven months may not have 
allowed adequate time for PCP to implement all 
changes. 
Next Steps
• Complete chart review and analysis of the remaining 
identified patients.
• Compare data with a matched-control group to 
determine the value of HRM consult recommendations 
and the clinical pharmacist in reducing HRM use in older 
patients at high risk to fall. 
Characteristics Results
Gender (%) Female 67%
Age (avg. in years) 84
Pathways 1 12
2 11
3 9
4 14
PCP follow-up within 3 months of fall (%) 91%
PharmD or Geriatric E-consult (%) 54%
Time spent on PharmD consult (avg. in minutes) 43.7 
Number of HRMs (avg.) 4.3
Number of HRM drug classes (avg.) 3
% with A1c goal defined in chart 50%
% with BP goal defined in chart 31%
In the year prior to SAFER enrollment, % with any 
systolic blood pressure <110mmHg 
59%
% with prior orthostatic measurement 35%
DEXA No history of DEXA 50%
DEXA w/in 3 years 20%
Last DEXA >3 years 30.4%
% on Vitamin D 56.5%
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Pre- and Post SAFER Medication Changes
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Accepted Recommendations by SAFER Pathway
# Accepted Recommendations # of Recommendations
Health & Services
45%
20%
15%
10%
5%
5%
Recommended Additions 
Implemented by PCP
DEXA
Orthostatics
Vitamin D
Bisphosphonate
Non-opioid
Analgesic
Lab Monitoring
33%
27%
13%
9%
9%
4%
3%
2%
Percentage of Patients on High-Risk 
Medications
Antihypertensive
Anticoagulant/
Antiplatelet
Antidepressant
Antimuscarinic/
Anticholinergic
Opioids
Anticonvulsant
Antidiabetic
Benzodiazepine
*Includes PRNs
